Kymera Therapeutics, Inc. (KYMR)

NASDAQ

$110.00

$-4.97

(-4.32%)

Pre-Market

Kymera Therapeutics, Inc. (KYMR) Live Price Chart

Last updated: ⁦2026-10-20 08:51:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Kymera Therapeutics, Inc. (KYMR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $110.00, with a market capitalization of $8.71B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $55.26 to $130.05. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$8.71B
Open	$114.97
Day's High	$130.05
Day's Low	$9.60
Previous Close	$108.07
Volume	8.00
Average Volume	729.24K
P/E Ratio	--
52-Week High	$130.05
52-Week Low	$55.26
Dividend Yield	--
Earnings Date	--

Kymera Therapeutics, Inc. (KYMR) Pre-Market Stock Price

Kymera Therapeutics, Inc. (KYMR) is trading at $110.00 in pre-market trading as of 2026-10-20 08:15:00, up 1.79% ($1.93) from the previous close of $108.07

Pre-market trading shows how investors are pricing KYMR before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Kymera Therapeutics, Inc. (KYMR) 7-Day Stock Price Change

Over the past seven days, Kymera Therapeutics, Inc. (KYMR) moved from $112.40 to $110.00, representing a decline of 2.13% ($2.40).

The stock traded between $104.39 and $115.82 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 806.37 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

KYMR 52-Week Price Position

Position in Range: 73.2%

52W Low$55.26

52W High$130.05

KYMR is currently trading at $110.00, placing it 73.2% of the way from its 52-week low of $55.26 to its 52-week high of $130.05. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Kymera Therapeutics, Inc. (KYMR)?

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Kymera Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	273
Exchange	NASDAQ
Company Website	https://www.kymeratx.com

How to Buy Kymera Therapeutics, Inc. (KYMR) Stock on MEXC

Eligible investors can buy real shares of Kymera Therapeutics, Inc. (KYMR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for KYMR and Place Your Order

Open the RealStocks trading page and search for KYMR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Kymera Therapeutics, Inc. (KYMR) stock price today?

Kymera Therapeutics, Inc. (KYMR) is currently trading at $ 110.00, up 1.79% ($1.93) from the previous close of $ 108.07. Intraday prices update in real time during regular trading hours.

2.Is KYMR stock going up or down today?

As of 2026-10-20 08:15:00, KYMR is trading at $ 110.00, up 1.79% ($1.93) from its previous close of $ 108.07. The stock has traded between $ 9.60 and $ 130.05 during today’s regular session. Past price movements do not guarantee future results.

3.What is KYMR pre-market price?

As of 2026-10-20 08:15:00, KYMR is trading at $ 110.00 in pre-market trading, up 1.79% ($1.93) from the previous close of $ 108.07. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is KYMR after-hours price?

As of 2026-10-20 08:15:00, KYMR is trading at $ 114.97 in after-hours trading, up 6.38% ($6.90) from the regular-session close of $ 108.07. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is KYMR stock trading now?

KYMR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does KYMR sit relative to its 52-week high and low?

Over the past 52 weeks, KYMR has traded between a low of $ 55.26 and a high of $ 130.05. At $ 110.00, the stock is positioned 73.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Kymera Therapeutics, Inc. in?

Kymera Therapeutics, Inc. (KYMR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Kymera Therapeutics, Inc.'s market capitalization and where is it listed?

Kymera Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 8.71B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is KYMR valued in terms of P/E ratio and EPS?

KYMR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.60. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Kymera Therapeutics, Inc. pay a dividend?

Kymera Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.